Palamar Joseph J, Fitzgerald Nicole, Carr Thomas H, Cottler Linda B, Ciccarone Daniel
NYU School of Medicine, Department of Population Health, New York, NY.
University of Florida, Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, United States.
Int J Drug Policy. 2025 Apr;138:104417. doi: 10.1016/j.drugpo.2024.104417. Epub 2024 May 13.
Rates of synthetic opioid-related deaths over time and across regions have been compared within the US, but other indicator data could help inform prevention and harm reduction as well. We compared regional trends in fentanyl seizures to examine potential shifts in illicit fentanyl availability.
Annual trends in fentanyl seizures were examined using data from High Intensity Drug Trafficking Areas for the US overall and by region from 2017 through 2023. Multiple measures included the number of seizures, the number of powder seizures, the number of pill seizures, the total weight of seizures, the number of pills seized, and the percentage of the number of pill seizures relative to the number of total seizures.
The percentage of seizures in pill form in the US increased from 10.3 % in 2017 to 49.0 % in 2023 (adjusted annual percentage change [AAPC]=25.2, 95 % CI: 17.6, 33.2), with 115.6 million individual pills seized in 2023. Pill weight related to total seizure weight also increased from 0.4 % to 54.5 % (AAPC=112.6, 95 % CI: 78.6, 153.2). In 2023, the plurality of seizures was in the West, in seven out of eight of our measures, with 77.8 % of seizures in the West being in pill form. Although the Midwest had lower prevalence of seizures than the West, there were notable increases in the Midwest in the number of pill seizures (AAPC=142.2, 95 % CI: 91.9, 205.8) and number of pills seized (AAPC=421.0, 95 % CI: 272.7, 628.4). Total weight of fentanyl seized increased the most in the West (AAPC=84.6, 95 % CI: 72.3, 97.8).
The number and size of fentanyl seizures is increasing in the US, with the majority of seizures, especially in pill form, in the West. Continued monitoring of regional shifts in the fentanyl supply can help inform targeted prevention and public health response.
在美国,已对合成阿片类药物相关死亡的发生率随时间和地区的变化进行了比较,但其他指标数据也有助于为预防和减少伤害提供信息。我们比较了芬太尼缉获量的区域趋势,以研究非法芬太尼供应的潜在变化。
利用2017年至2023年美国高强度贩毒地区的数据,研究了芬太尼缉获量的年度趋势。多项指标包括缉获次数、粉末缉获次数、药丸缉获次数、缉获总量、药丸缉获数量以及药丸缉获次数占总缉获次数的百分比。
美国药丸形式的缉获量百分比从2017年的10.3%增至2023年的49.0%(调整后年度百分比变化[AAPC]=25.2,95%置信区间:17.6,33.2),2023年共缉获1.156亿粒药丸。药丸重量占总缉获重量的比例也从0.4%增至54.5%(AAPC=112.6,95%置信区间:78.6,153.2)。2023年,多数缉获发生在西部,在我们的八项指标中有七项如此,西部77.8%的缉获为药丸形式。尽管中西部的缉获发生率低于西部,但中西部的药丸缉获次数(AAPC=142.2,95%置信区间:91.9,205.8)和药丸缉获数量(AAPC=421.0,95%置信区间:272.7,628.4)有显著增加。西部芬太尼的缉获总量增长最多(AAPC=84.6,95%置信区间:72.3,97.8)。
美国芬太尼缉获量的数量和规模在增加,多数缉获,尤其是药丸形式的缉获,发生在西部。持续监测芬太尼供应的区域变化有助于为有针对性的预防和公共卫生应对提供信息。